본문 바로가기
KERD
논문KCI 등재

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods

Makoto Naganuma|Tadakazu Hisamatsu|Takanori Kanai|Katsuyoshi Matsuoka|Atsushi Hayashi
대한내과학회 (The Korean Association Of Internal Medicine)|2014.07|The Korean Journal of Internal Medicine|제29권 제4호|pp. 409-415|DOI http://dx.doi.org/10.3904/kjim.2014.29.4.409

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

DietInflammatory bowel diseasesProbioticsMicrobiotaJapanese food
주제분류내과학

초록

The incidence and prevalence of inflammatory bowel diseases (IBDs) includingulcerative colitis and Crohn disease are rapidly increasing in Western countriesand in developed Asian countries. Although biologic agents targeting the immunesystem have been effective in patients with IBD, cessation of treatmentleads to relapse in the majority of patients, suggesting that intrinsic immune dysregulationis an effect, not a cause, of IBD. Dramatic changes in the environment,resulting in the dysregulated composition of intestinal microbiota or dysbiosis,may be associated with the fundamental causes of IBD. Japan now has upgradedwater supply and sewerage systems, as well as dietary habits and antibiotic overusethat are similar to such features found in developed Western countries. Thepurpose of this review article was to describe the association of diet, particularlyJapanese food and microbiota, with IBD.

Abstract

The incidence and prevalence of inflammatory bowel diseases (IBDs) includingulcerative colitis and Crohn disease are rapidly increasing in Western countriesand in developed Asian countries. Although biologic agents targeting the immunesystem have been effective in patients with IBD, cessation of treatmentleads to relapse in the majority of patients, suggesting that intrinsic immune dysregulationis an effect, not a cause, of IBD. Dramatic changes in the environment,resulting in the dysregulated composition of intestinal microbiota or dysbiosis,may be associated with the fundamental causes of IBD. Japan now has upgradedwater supply and sewerage systems, as well as dietary habits and antibiotic overusethat are similar to such features found in developed Western countries. Thepurpose of this review article was to describe the association of diet, particularlyJapanese food and microbiota, with IBD.

참고문헌 (60)

  1. "Annual report 2012 from Japan Intractable Diseases Information Center" (2014)[URL]
  2. Asakura H, "Is there a link between food and intestinal microbes and the occurrence of Crohn’s disease and ulcerative colitis?", J Gastroenterol Hepatol, 23, pp.1794~1801 (2008)
  3. Danese S, "Ulcerative colitis", N Engl J Med, 365, pp.1713~1725 (2011)
  4. Molodecky NA, "Increasing incidence and prevalence of the inf lammatory bowel diseases with time, based on systematic review", Gastroenterology, 142, pp.46~54 (2012)
  5. Jostins L, "Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease", Nature, 491, pp.119~124 (2012)
  6. Aujnarain A, "The role of the environment in the development of pediatric inf lammatory bowel disease", Curr Gastroenterol Rep, 15, pp.326~ (2013)
  7. Leone V, "Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases", J Gastroenterol, 48, pp.315~321 (2013)
  8. Goldsmith JR, "The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications", J Gastroenterol, 49, pp.785~798 (2014)
  9. Kostic AD, "The microbiome in inflammatory bowel disease: current status and the future ahead", Gastroenterology, 146, pp.1489~1499 (2014)
  10. Manichanh C, "The gut microbiota in IBD", Nat Rev Gastroenterol Hepatol, 9, pp.599~608 (2012)
  11. Kaur N, "Intestinal dysbiosis in inf lammatory bowel disease", Gut Microbes, 2, pp.211~216 (2011)
  12. Knights D, "Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome", Gut, 62, pp.1505~1510 (2013)
  13. Neuman MG, "Inf lammatory bowel disease:role of diet, microbiota, life style", Transl Res, 160, pp.29~44 (2012)
  14. Wu GD, "Linking long-term dietary patterns with gut microbial enterotypes", Science, 334, pp.105~108 (2011)
  15. Sommer F, "The gut microbiota: masters of host development and physiology", Nat Rev Microbiol, 11, pp.227~238 (2013)
  16. Cho I, "Antibiotics in early life alter the murine colonic microbiome and adiposity", Nature, 488, pp.621~626 (2012)
  17. Ivanov, II, "Intestinal commensal microbes as immune modulators", Cell Host Microbe, 12, pp.496~508 (2012)
  18. Human Microbiome Project Consortium, "A framework for human microbiome research", Nature, 486, pp.215~221 (2012)
  19. Blaser M, "The microbiome explored: recent insights and future challenges", Nat Rev Microbiol, 11, pp.213~217 (2013)
  20. Blumberg R, "Microbiota, disease, and back to health: a metastable journey", Sci Transl Med, 4, pp.137~ (2012)
  21. Spor A, "Unravelling the effects of the environment and host genotype on the gut microbiome", Nat Rev Microbiol, 9, pp.279~290 (2011)
  22. Clemente JC, "The impact of the gut microbiota on human health: an integrative view", Cell, 148, pp.1258~1270 (2012)
  23. Kamada N, "Role of the gut microbiota in immunity and inflammatory disease", Nat Rev Immunol, 13, pp.321~335 (2013)
  24. Tyler AD, "Analyzing the human microbiome: a “how to” guide for physicians", Am J Gastroenterol (2014)[DOI]
  25. Cox MJ, "Sequencing the human microbiome in health and disease", Hum Mol Genet, 22(R1), pp.R88~R94 (2013)
  26. McCarthy JJ, "Genomic medicine:a decade of successes, challenges, and opportunities", Sci Transl Med, 5, pp.184~189 (2013)
  27. Weinstock GM, "Genomic approaches to studying the human microbiota", Nature, 489, pp.250~256 (2012)
  28. Sweeney TE, "The human gut microbiome:a review of the effect of obesity and surgically induced weight loss", JAMA Surg, 148, pp.563~569 (2013)
  29. Cho I, "The human microbiome: at the interface of health and disease", Nat Rev Genet, 13, pp.260~270 (2012)
  30. Round JL, "The gut microbiota shapes intestinal immune responses during health and disease", Nat Rev Immunol, 9, pp.313~323 (2009)
  31. Collins SM, "The interplay between the intestinal microbiota and the brain", Nat Rev Microbiol, 10, pp.735~742 (2012)
  32. Simren M, "Intestinal microbiota in functional bowel disorders: a Rome foundation report", Gut, 62, pp.159~176 (2013)
  33. Power SE, "Intestinal microbiota, diet and health", Br J Nutr, 111, pp.387~402 (2014)
  34. Walsh CJ, "Benef icial modulation of the gut microbiota", FEBS Lett (2014)[DOI]
  35. Le Chatelier E, "Richness of human gut microbiome correlates with metabolic markers", Nature, 500, pp.541~546 (2013)
  36. Holmes E, "Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk", Cell Metab, 16, pp.559~564 (2012)
  37. Nicholson JK, "Host-gut microbiota metabolic interactions", Science, 336, pp.1262~1267 (2012)
  38. De Filippo C, "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa", Proc Natl Acad Sci U S A, 107, pp.14691~14696 (2010)
  39. Yatsunenko T, "Human gut microbiome viewed across age and geography", Nature, 486, pp.222~227 (2012)
  40. D’Haens GR, "Future directions in inf lammatory bowel disease management", J Crohns Colitis (2014)[DOI]
  41. Richman E, "Review article: evidence-based dietary advice for patients with inf lammatory bowel disease", Aliment Pharmacol Ther, 38, pp.1156~1171 (2013)
  42. Guarner F, "Hygiene, microbial diversity and immune regulation", Curr Opin Gastroenterol, 23, pp.667~672 (2007)
  43. Spooren CE, "Review article: the association of diet with onset and relapse in patients with inf lammatory bowel disease", Aliment Pharmacol Ther, 38, pp.1172~1187 (2013)
  44. Hou JK, "Diet and inflammatory bowel disease: review of patient-targeted recommendations", Clin Gastroenterol Hepatol (2013)[DOI]
  45. Ananthakrishnan AN, "A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis", Gastroenterology, 145, pp.970~977 (2013)
  46. Devkota S, "Nutrition, microbiomes, and intestinal inf lammation", Curr Opin Gastroenterol, 29, pp.603~607 (2013)
  47. Veldhoen M, "Dietary influences on intestinal immunity", Nat Rev Immunol, 12, pp.696~708 (2012)
  48. Garrett WS, "Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system", Cell, 131, pp.33~45 (2007)
  49. Turnbaugh PJ, "An obesity-associated gut microbiome with increased capacity for energy harvest", Nature, 444, pp.1027~1031 (2006)
  50. Atarashi K, "Induction of colonic regulatory T cells by indigenous Clostridium species", Science, 331, pp.337~341 (2011)
  51. Atarashi K, "Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota", Nature, 500, pp.232~236 (2013)
  52. Furusawa Y, "Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells", Nature, 504, pp.446~450 (2013)
  53. Arpaia N, "Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation", Nature, 504, pp.451~455 (2013)
  54. Smith PM, "The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis", Science, 341, pp.569~573 (2013)
  55. Hayashi A, "A single strain of Clostridium butyricum induces intestinal IL-10-pro ducing macrophages to suppress acute experimental colitis in mice", Cell Host Microbe, 13, pp.711~722 (2013)
  56. Devkota S, "Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-", - mice, 2012, pp.487, 104~108
  57. Takaishi H, "Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inf lammatory bowel disease", Int J Med Microbiol, 298, pp.463~472 (2008)
  58. van Nood E, "Duodenal infusion of donor feces for recurrent Clostridium difficile", N Engl J Med, 368, pp.407~415 (2013)
  59. Kahn SA, "Patient perceptions of fecal microbiota transplantation for ulcerative colitis", Inflamm Bowel Dis, 19, pp.1506~1513 (2013)
  60. Smits LP, "Therapeutic potential of fecal microbiota transplantation", Gastroenterology, 145, pp.946~953 (2013)

관련 논문AI추천

Microbial Modulation in Inflammatory Bowel DiseasesCheon Jae Hee, Yu Jongwook대한면역학회 · Immune Network2022 · 제22권 제6호Host-microbial Cross-talk in Inflammatory Bowel DiseaseHiroko Nagao-Kitamoto, Nobuhiko Kamada대한면역학회 · Immune Network2017 · 제17권 제1호Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the TunnelEugene B. Chang, Laura E. Raffals거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제4호Incidence and Prevalence of Inflammatory Bowel Disease across Asia박지혜, 천재희연세대학교의과대학 · Yonsei Medical Journal2021 · 제62권 제2호Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies김덕환, 천재희대한면역학회 · Immune Network2017 · 제17권 제1호Gut Microbiota in Inflammatory Bowel Disease심정옥대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2013 · 제16권 제1호

이 간행물의 다른 논문 (5건)

Can we more efficiently save patients with vitamin K-dependent coagulopathy caused by superwarfarin intoxication?박진희pp. 430-433The effect of 5-aminoimidazole-4-carboxamideribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells최현정, 김태용, 김원배, 송영기, 김원구pp. 474-481Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients박훈석, 양철우, 홍유아, 선인오, 진동찬, 김영수, 김형욱, 김용수, 박철휘, 최범순, 정병하pp. 482-488A case of myocardial involvement in lung cancer that mimics ST segment elevation in myocardial infarction김계훈, 윤현주, 안영근, 정명호, 조정관, 박종춘, 강정채pp. 525-528Successful treatment with clarithromycin for patients with polymyalgia rheumaticaMasashi Ohe, Toshiyuki Bohgakipp. 539-541
원문 보기